VivoSim Labs receives Nasdaq delisting notice; subsequent transactions restore equity above $2.5M

VivoSim Labs, INC.

Received Nasdaq delisting notice on July 20, 2026 for failing to maintain $2.5M minimum stockholders' equity; equity was $(1,099,000) as of March 31, 2026.
Company has 45 days (until Sept 3, 2026) to submit a compliance plan; Nasdaq may grant up to 180-day extension.
Subsequent transactions boosted equity above $2.5M: $5M milestone from Eli Lilly, $4M private placement, and $5.1M from warrant exercises.
As of filing, stockholders' equity exceeds $2.5M and shares outstanding are 12,057,789.
No immediate effect on listing; stock continues trading under VIVS on Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.